Low-molecular-weight heparin for the prevention of preeclampsia in high-risk pregnancies without thrombophilia: a systematic review and meta-analysis
Abstract Objectives To systematically evaluate the efficacy of low molecular weight heparin (LMWH) to prevent preeclampsia in high risk pregnant women without thrombophilia. Search strategy PubMed, Embase and the Cochrane library were searched for articles published before 1st August 2022 using the...
Main Authors: | Jiahui Chen, Jing Huai, Huixia Yang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2024-01-01
|
Series: | BMC Pregnancy and Childbirth |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12884-023-06218-9 |
Similar Items
-
Low-molecular-weight heparin in addition to low-dose aspirin for preventing preeclampsia and its complications: A systematic review and meta-analysis
by: Li Zheng, et al.
Published: (2022-12-01) -
Efficacy and safety of low-dose aspirin combined with low-molecular-weight heparin in treatment of preeclampsia: a meta-analysis and systematic review
by: Chunfeng Wu, et al.
Published: (2021-05-01) -
The role of low molecular weight heparin in women with hereditary thrombophilia for good perinatal outcome
by: Vesna Sokol, et al.
Published: (2016-01-01) -
THROMBOPHILIAS IN OBSTETRICIAN AND GYNECOLOGICAL PRACTICE, HEPARIN PREVENTION
by: A. P. Momot, et al.
Published: (2017-10-01) -
PRINCIPLES OF PREGRAVID PREPARATION AND MANAGEMENT OF PREGNANT WOMEN WITH PREECLAMPSIA IN THE BACKGROUND OF THROMBOPHILIA
by: H. L. Atabaeva
Published: (2017-03-01)